Stocks to sell

When I last wrote about Vaxart (NASDAQ:VXRT) last month I indicated that I felt that the biotech company was not worth more than about $1 per share. As of June 16, VXRT stock was at $7.67, or $1.00 higher than when I wrote about it on May 14 at $6.61. Source: Photo courtesy of Vaxart,

While Senseonics (NYSE:SENS) stock has a great deal of potential, the shares currently have a fairly high valuation. Source: Minerva Studio / Shutterstock.com Moreover, in the short-term and medium-term, SENS stock looks poised to fall significantly. Senseonics has developed Eversense, a 90-day continuous glucose monitoring (CGM) system. According to the company, the device provides continuous

With Zomedica’s  (NYSE:ZOM) new Truforma diagnostic tool possibly facing a great deal of entrenched competition, the outlook of ZOM stock is, at best, difficult to determine. Meanwhile, the shares have a very high valuation. Source: didesign021 / Shutterstock.com A diagnostic product meant to be used by veterinarians, Truforma measures the amount of T4 and TSH

Fisker (NYSE:FSR) detailed ongoing operating and capital spending plans in its latest Q1 earnings release on May 17. A capital raise looks likely for the electric vehicle (EV) car maker, and likely to wreak havoc on FSR stock, at least until investors have visibility on when, exactly, they can expect Fisker to start producing free

There’s been plenty of talk about GameStop (NYSE:GME) stock going to the moon in 2021. At the same time, there’s been plenty of people pounding the table that the stock is overvalued. Source: Northfoto / Shutterstock.com For sure, GME stock is overvalued compared to where it was just a year ago. The stock is up

MicroVision is still up for sale, just like the CEO said it was and the latest 10-Q report indicates. Unfortunately, there are still no buyers. Source: Shutterstock For some reason, the market thinks a deal will happen when the stock is at a market value of $3.41 billion. Allow me to provide an evidently-needed reality

For some strange reason, Reddit’s WallStreetBets embraced the short-squeeze of AMC Entertainment Holdings (NYSE:AMC). While its business is on the cusp of recovering, its earnings will not get anywhere near a level that justifies its valuation. Its market capitalization, which exceeded that of GameStop (NYSE:GME) at the end of last week, is most puzzling. For

Sundial Growers (NASDAQ:SNDL) now reportedly has 1.1 billion CAD in cash on its balance sheet, at least according to one analyst. My calculations show that SNDL stock is not worth anywhere near its present price. Source: Shutterstock The company said during its recent first quarter conference call that it has over 1 billion CAD in

The economic numbers keep rolling in and they continue to look good. Jobless claims are falling. Hiring demand is rising. There’s money in the system. It’s all very attractive. But that’s what we’re seeing right now. The market isn’t really interested in right now. It’s looking at right now and making predictions on six months

QuantumScape (NYSE:QS) went from a hot special purpose acquisition company (SPAC) to damaged goods in record time. Back in December, QS stock traded for $130 per share. Just six months later, QuantumScape has lost a crushing 75% of its value. Source: Michael Vi / Shutterstock.com Why did electric vehicle (EV) battery maker QuantumScape power down

Despite intense competition and the easing of the COVID pandemic restrictions, Zoom Video Communications (NASDAQ:ZM) is still zooming. ZM stock? Not so much. Zoom’s first fiscal quarter (April) results justified all the past faith that investors put into it. The company earned $227 million, 74 cents per share fully diluted, on revenue of $947 million.

InvestorPlace columnist Brenden Rearick recently discussed Castor Maritime’s (NASDAQ:CTRM) first profitable quarter since 2019. Interestingly, despite the positive results, CTRM stock fell on the news.  Source: Pavel Kapysh / Shutterstock.com Rearick points out that the company is ready to take advantage of the “strong demand for dry bulk transportation services” with 18 dry bulk carriers

Biogen (NASDAQ:BIIB) stock ripped higher this week on approval of its Alzheimer’s drug, Aduhelm. Source: PictureDesignSwiss / Shutterstock.com Analysts seemed taken with Biogen’s proposed pricing, $56,000 per year. It’s based on the cost of Alzheimer’s in lost life and nursing care. A scientific panel refused to endorse the drug last year. The panel voted 8-1

Given the recent short squeeze attempts on meme stocks like AMC (NYSE:AMC) and GameStop (NYSE:GME), it’s no surprise that investors have been searching for juice among similar stocks with high short interest. Enter Churchill Capital Corp IV (NYSE:CCIV), a high profile SPAC (Special Purpose Acquisition Company), which currently has 26% of its float in short

I like cruising. In fact, I especially like the Celebrity line from Royal Caribbean (NYSE:RCL). But I would no more buy RCL stock than I would Gamestop (NYSE:GME). The numbers just don’t make sense. Source: ImagineStock / Shutterstock.com Royal Caribbean opened for trade on Jun. 11 near $89 per share. That’s a market capitalization of

Naked Brand (NASDAQ:NAKD) released its latest prospectus on May 18 showing that the company now has roughly 813.8 million shares outstanding. This allows us to calculate its actual market value. Currently, NAKD has a market cap of $626 million at yesterday’s price of 77 cents for NAKD stock. As a result, the stock looks to be

There are multiple reasons to be bearish on Canoo (NASDAQ:GOEV) stock. And there are a lot of reasons to believe Canoo will lag behind the broader electric vehicle market for the foreseeable future as well. I’ll get into those too. Source: Shutterstock But one of the most current and powerful forces that will keep GOEV

If you’re a spiritually-minded person perhaps you can send up thoughts and prayers for people who own Workhorse Group (NYSE:WKHS) stock. Source: rblfmr / Shutterstock.com The company has limited revenue and even more limited prospects for the same. It faces scalability concerns in a sector with growing competition, and yet there are diamond hands within the

The CEO of AMC (NYSE:AMC) recently argued that the company was helping its current shareholders by selling more shares of AMC stock. Source: Helen89 / Shutterstock.com “If I was a shareholder, I’d be more concerned that we don’t have shares available to us because I think shares are a very powerful tool to do good

Tilray (NASDAQ:TLRY) stock is giving up gains after completing its monumental merger with Aphria. Source: Jarretera / Shutterstock.com The merger has created the world’s largest cannabis company by Pro-forma revenue. After peaking at $67 in early February, shares are down. It will open today at around $22. Now that the dust has settled on the